Aldawaa Medical Services Co. (DMSCO) reported a net profit of SAR 191.2 million for the first half of 2024, a jump of 15.5% from SAR 165.6 million in H1 2023.
Item | 6m 2023 | 6m 2024 | Change |
---|---|---|---|
Revenues | 2,844.33 | 3,102.69 | 9.1 % |
Gross Income | 1,060.62 | 1,140.39 | 7.5 % |
Operating Income | 242.28 | 269.08 | 11.1 % |
Net Income | 165.59 | 191.21 | 15.5 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.95 | 2.25 | 15.5 % |
The first-half profit was triggered by better revenue, thanks to increased sales activities, own brands, and omnichannels.
The increase in sales boosted gross profit by SAR 79.7 million, or 7.5% compared to H1 2023. Additionally, the company’s cost control led to a rise of SAR 28.2 million, or 11.9% year-on-year (YoY), in operating profits.
In Q2 2024, net earnings increased by 7% to SAR 95.9 million from SAR 89.3 million in Q2 2023 on improved revenue amid increased sales activities, the company’s brands, and omnichannels.
Aldawaa’s net earnings were 0.6% up on a sequential basis from SAR 95.3 million in Q1 2024 as higher sales raised gross profit by 2% quarter-on-quarter (QoQ).
Item | Q2 2023 | Q2 2024 | Change |
---|---|---|---|
Revenues | 1,436.74 | 1,586.27 | 10.4 % |
Gross Income | 525.64 | 575.97 | 9.6 % |
Operating Income | 126.28 | 136.31 | 7.9 % |
Net Income | 89.33 | 95.88 | 7.3 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.05 | 1.13 | 7.3 % |
Item | Q1 2024 | Q2 2024 | Change |
---|---|---|---|
Revenues | 1,516.42 | 1,586.27 | 4.6 % |
Gross Income | 564.42 | 575.97 | 2.0 % |
Operating Income | 130.49 | 136.31 | 4.5 % |
Net Income | 95.33 | 95.88 | 0.6 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.12 | 1.13 | 0.6 % |
Total shareholders’ equity, no minority interest, rose to SAR 1.37 billion as of June 30, 2024, from SAR 1.25 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}